Furthermore, recombinant human VEGF enhances the angiotensin II-induced AAA formation in apolipoprotein E-deficient mice [11], suggesting that increased expressions of VEGF and their receptors may impact different pathways involved in the AAA etiology. Here, APOE is linked to triple-A syndrome.